This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
over 2
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

In this study, Malathion Gel 0.5% will be compared to Nix (permethrin 1%) as a treatment for head lice in patients 2 years of age and older. Malathion Gel 0.5% is a new formulation of an established head lice treatment. The new formulation has been evaluated in 2 previous studies of patients 2 years of age and older.

Provided treatments

  • Drug: Malathion gel 0.5%
  • Drug: Permethrin 1% rinse
Tris trial is registered with FDA with number: NCT00927472. The sponsor of the trial is Taro Pharmaceuticals USA and it is looking for 254 volunteers for the current phase.
Official trial title:
A Multi-Center Phase III Study to Evaluate Ovide Lotion 0.5% Formulation, for the Control of Head Lice in Pediatric Subjects and Adult Subjects With Pediculosis Capitis